🔴 Nyxoah is trading 5.1% down today with no new company-specific catalyst identified

Nyxoah is trading at $1.67 (-5.11%) on September 4, 2026; no new company-specific catalyst directly explaining the decline was identified.

• It closed at $1.76 on September 3.
• The decline follows the prior session’s 16.56% rally after ACCCESS trial results met primary endpoints, including 77.2% AHI and 87.7% ODI responder rates, with no device-related serious adverse events.
• Broader indexes were only modestly lower.